This is free case-based activity that includes discussion of a forty-four year old man presents with fatigue that has been worsening over 3 weeks. A complete blood count shows a hematocrit of 25%, a white blood cell count of 17,000/mm3 with frequent blasts, and a platelet count of 46,000/mm3. A bone marrow examination shows 40% myeloblasts. Fluorescence in situ hybridization shows monosomy 7 and 5q- in the majority of blasts.
- Identify those diagnostic tests that are necessary for allocating younger patients with AML to the most appropriate therapies
- Discuss the possible induction therapies available as initial therapy for patients with AML
- Define the categories of patients with AML for whom hematopoietic cell transplantation is an appropriate therapeutic option
- AMA PRA Category 1 Credits™
- Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
- Certificate of Completion may be used to document participation, but no credit will be conferred.
- This course expires on November 18, 2018. Participants must complete all necessary course components by this date to receive credit.